Clinical Trials Directory

Trials / Unknown

UnknownNCT02022722

Trigger Point Injections and Pelvic Rehabilitation for the Treatment of Pelvic Floor Myalgia and Sexual Pain

Assessment Of Pain Subsidence And Sexual Function Amelioration Using Either Pelvic Rehabilitation Or Trigger Point Injections

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
36 (estimated)
Sponsor
University of Cincinnati · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate which treatment option for pelvic floor pain allows for improved sexual function.

Detailed description

Pelvic floor pain may be treated with trigger point injections with medications (steroids and local anesthetics) that are FDA approved for injection into muscles. The alternative is a noninvasive treatment option using pelvic rehabilitation which involves vaginal muscle massage. Both treatment options have been used and reported; however, rapidity of improvement and return to normal sexual function have not been assessed. This study assigns patients to either treatment option randomly and the sexual function is assessed based on standardized sexual function questionnaires as well as pain ratings.

Conditions

Interventions

TypeNameDescription
DRUGTrigger Point Injections Triamcinolone Acetonide, Bupivacaine HydrochlorideThe mixture is injected into the levator muscles, with half the volume on each side of the pelvic musculature.
PROCEDUREPelvic RehabilitationPelvic floor massage will be performed on a weekly basis by a licensed physiotherapist specialized in pelvic floor pelvic therapy

Timeline

Start date
2013-08-01
Primary completion
2014-04-01
Completion
2014-06-01
First posted
2013-12-30
Last updated
2013-12-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02022722. Inclusion in this directory is not an endorsement.